BiotechTube
Home/Zentalis Pharmaceuticals/Ingmar Bruns, M.D.
IB

Ingmar Bruns, M.D.

Chief Medical Officer

Zentalis Pharmaceuticals

Therapeutic Areas

Oncology

Zentalis Pharmaceuticals Pipeline

DrugIndicationPhase
Azenosertib (ZN-c3)Cyclin E1+ Platinum-Resistant Ovarian Cancer (PROC)Phase 2

Leadership Team at Zentalis Pharmaceuticals

JE
Julie Eastland
Chief Executive Officer, President and Director
WC
Wendy Chang
Chief People Officer
View full Zentalis Pharmaceuticals profile